JPWO2021070934A1 - - Google Patents
Info
- Publication number
- JPWO2021070934A1 JPWO2021070934A1 JP2021551720A JP2021551720A JPWO2021070934A1 JP WO2021070934 A1 JPWO2021070934 A1 JP WO2021070934A1 JP 2021551720 A JP2021551720 A JP 2021551720A JP 2021551720 A JP2021551720 A JP 2021551720A JP WO2021070934 A1 JPWO2021070934 A1 JP WO2021070934A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G01N33/548—Carbohydrates, e.g. dextran
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4724—Lectins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
- G01N2333/8121—Serpins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
- G01N2333/8121—Serpins
- G01N2333/8125—Alpha-1-antitrypsin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019187197 | 2019-10-11 | ||
| JP2019187197 | 2019-10-11 | ||
| PCT/JP2020/038300 WO2021070934A1 (ja) | 2019-10-11 | 2020-10-09 | がんの検査方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021070934A1 true JPWO2021070934A1 (cg-RX-API-DMAC7.html) | 2021-04-15 |
| JPWO2021070934A5 JPWO2021070934A5 (cg-RX-API-DMAC7.html) | 2023-10-13 |
| JP7656829B2 JP7656829B2 (ja) | 2025-04-04 |
Family
ID=75438180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021551720A Active JP7656829B2 (ja) | 2019-10-11 | 2020-10-09 | がんの検査方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12618842B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4043881A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7656829B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102896955B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN114556101B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021070934A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022182394A (ja) * | 2021-05-28 | 2022-12-08 | 独立行政法人国立病院機構 | 抗原固相化デバイス |
| WO2025187809A1 (ja) * | 2024-03-08 | 2025-09-12 | 富士フイルム株式会社 | 検出対象物質を免疫学的に検出する方法、非特異反応を抑制する方法、フコース含有組成物、および試薬キット |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017061449A1 (ja) * | 2015-10-05 | 2017-04-13 | 国立研究開発法人産業技術総合研究所 | がん細胞の検出方法、がん細胞内に物質を導入するための試薬、及びがん治療用組成物 |
| WO2018190357A1 (ja) * | 2017-04-11 | 2018-10-18 | 国立研究開発法人産業技術総合研究所 | レクチンの固定化方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596476B1 (en) * | 1989-12-22 | 2003-07-22 | Abbott Laboratories | Hepatitis C assay |
| JP5977743B2 (ja) | 2011-06-15 | 2016-08-24 | 三洋化成工業株式会社 | 磁性シリカ粒子を用いた測定方法及び該測定方法用試薬 |
| WO2013172105A1 (ja) * | 2012-05-18 | 2013-11-21 | 日東紡績株式会社 | 膵臓癌を検出するためのマーカー |
| WO2014126146A1 (ja) | 2013-02-14 | 2014-08-21 | 独立行政法人産業技術総合研究所 | 未分化細胞除去方法 |
| JP7386647B2 (ja) | 2018-08-13 | 2023-11-27 | 東ソー株式会社 | 糖鎖への親和性が向上したフコース結合性タンパク質、およびその製造方法 |
-
2020
- 2020-10-09 EP EP20873535.7A patent/EP4043881A4/en active Pending
- 2020-10-09 CN CN202080071169.XA patent/CN114556101B/zh active Active
- 2020-10-09 WO PCT/JP2020/038300 patent/WO2021070934A1/ja not_active Ceased
- 2020-10-09 JP JP2021551720A patent/JP7656829B2/ja active Active
- 2020-10-09 KR KR1020227012018A patent/KR102896955B1/ko active Active
-
2022
- 2022-04-11 US US17/717,764 patent/US12618842B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017061449A1 (ja) * | 2015-10-05 | 2017-04-13 | 国立研究開発法人産業技術総合研究所 | がん細胞の検出方法、がん細胞内に物質を導入するための試薬、及びがん治療用組成物 |
| WO2018190357A1 (ja) * | 2017-04-11 | 2018-10-18 | 国立研究開発法人産業技術総合研究所 | レクチンの固定化方法 |
Non-Patent Citations (2)
| Title |
|---|
| KOTHS, K. ET AL.: "Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defin", J. BIOL. CHEM., vol. 268, no. 19, JPN6020045702, 1993, pages 14245 - 14249, ISSN: 0005491703 * |
| 木明琢磨, 外: "血清糖タンパク質結合糖鎖を利用した新たな臨床マーカーの開発", 臨床病理, vol. 62, JPN6020045700, 2014, pages 140, ISSN: 0005491702 * |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220079855A (ko) | 2022-06-14 |
| JP7656829B2 (ja) | 2025-04-04 |
| EP4043881A1 (en) | 2022-08-17 |
| WO2021070934A1 (ja) | 2021-04-15 |
| EP4043881A4 (en) | 2022-11-23 |
| US12618842B2 (en) | 2026-05-05 |
| KR102896955B1 (ko) | 2025-12-05 |
| US20220236275A1 (en) | 2022-07-28 |
| CN114556101A (zh) | 2022-05-27 |
| CN114556101B (zh) | 2025-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112019017762A2 (cg-RX-API-DMAC7.html) | ||
| BR112021008711A2 (cg-RX-API-DMAC7.html) | ||
| BR112019016141A2 (cg-RX-API-DMAC7.html) | ||
| AU2020104490A5 (cg-RX-API-DMAC7.html) | ||
| BR112021013944A2 (cg-RX-API-DMAC7.html) | ||
| BR112019016142A2 (cg-RX-API-DMAC7.html) | ||
| BR112021012348A2 (cg-RX-API-DMAC7.html) | ||
| BR112021013128A2 (cg-RX-API-DMAC7.html) | ||
| BR112019016136A2 (cg-RX-API-DMAC7.html) | ||
| BR102020025461B1 (pt) | Dispositivo e processo de conversão de compostos aromáticos por alquilação de benzeno por etileno | |
| BR102020020816B1 (pt) | Veículo, e, método para controlar o movimento de ar através de um veículo com uma ventoinha do veículo | |
| BR102020018650B1 (pt) | Método para preparar óxido de cálcio usando um forno pré- aquecedor de suspensão de múltiplos estágios | |
| BR102020017390B1 (pt) | Bomba multifásica | |
| BR102020011722B1 (pt) | Porta de tela para um pacote de radiadores | |
| BR112021022301B1 (pt) | Palmilha para inserção em calçado | |
| BR102020005860B1 (pt) | Controle de obstrução para um implemento agrícola | |
| BR112021010564B1 (pt) | Sistema de armadilha para animais e método de monitoramento do mesmo | |
| BR112021013954B1 (pt) | Sistema de cateter com confirmação da colocação do cateter dentro de uma veia | |
| BR102020000355B1 (pt) | Embreagem que tem dois estágios para aplicar torque variado entre um eixo de entrada e um eixo de saída | |
| BR102019027339B1 (pt) | Sistema de aspersão de água e difusor de sistema de aspersão de água | |
| BR102019026542B1 (pt) | Sistema para detectar e controlar a posição de spoiler de asa de aeronave | |
| BR102019026293B1 (pt) | Sistema de aeronave, e, método para transmitir energia de um primeiro componente para um segundo componente | |
| BR102019026215B1 (pt) | Sinalizador acústico | |
| BR102019026001B1 (pt) | Disposição de controle de atuador, e, disposição de controle de spoiler para uma aeronave | |
| BR102019025742B1 (pt) | Máquina desbastadora de cenoura |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20220404 |
|
| AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20220621 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220819 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231004 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20231004 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20241224 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250212 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250305 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250313 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7656829 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |